All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
The MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Patients with MPN are at increased risk of thrombosis and require treatment to prevent recurrent thromboembolic events. Anticoagulants suppress the synthesis or function of various clotting factors, thereby reducing thrombotic events. New types of anticoagulants are being investigated for the treatment of MPN.
Save to your areas of interest